Nantahala Capital Management LLC Invests $28.82 Million in Establishment Labs Holdings Inc. $ESTA

Nantahala Capital Management LLC acquired a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 335,830 shares of the company’s stock, valued at approximately $28,817,572. Establishment Labs makes up 0.0% of Nantahala Capital Management LLC’s portfolio, making the stock its 20th biggest position. Nantahala Capital Management LLC owned about 1.13% of Establishment Labs at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Simplify Asset Management Inc. raised its position in shares of Establishment Labs by 92.1% during the 4th quarter. Simplify Asset Management Inc. now owns 72,894 shares of the company’s stock valued at $5,313,000 after buying an additional 34,946 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Establishment Labs by 164.9% in the second quarter. Assenagon Asset Management S.A. now owns 135,897 shares of the company’s stock worth $11,661,000 after acquiring an additional 84,592 shares in the last quarter. Bank of America Corp DE grew its position in Establishment Labs by 56.7% in the first quarter. Bank of America Corp DE now owns 416,840 shares of the company’s stock worth $23,668,000 after acquiring an additional 150,797 shares in the last quarter. AlTi Global Inc. bought a new position in Establishment Labs in the first quarter valued at $842,000. Finally, Sigma Planning Corp increased its stake in Establishment Labs by 325.5% in the first quarter. Sigma Planning Corp now owns 20,424 shares of the company’s stock valued at $1,160,000 after acquiring an additional 15,624 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA opened at $70.64 on Friday. The company has a quick ratio of 2.52, a current ratio of 3.84 and a debt-to-equity ratio of 12.11. The stock has a market cap of $2.11 billion, a PE ratio of -53.92 and a beta of 1.07. The company’s fifty day moving average is $85.00 and its 200 day moving average is $74.91. Establishment Labs Holdings Inc. has a 52 week low of $36.53 and a 52 week high of $97.59.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Establishment Labs had a negative net margin of 15.82% and a negative return on equity of 196.69%. The business had revenue of $67.54 million for the quarter, compared to analysts’ expectations of $65.79 million. During the same quarter in the previous year, the company earned ($0.57) earnings per share. The business’s quarterly revenue was up 31.7% on a year-over-year basis. Research analysts anticipate that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on ESTA. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a research note on Wednesday, June 24th. Citigroup upgraded Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Thursday, August 13th. Needham & Company LLC raised their price objective on Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, August 6th. BTIG Research boosted their target price on Establishment Labs from $96.00 to $103.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Mizuho upped their target price on Establishment Labs from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 15th. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $100.25.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.